(Q44448583)

3 December 2017

title

Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human (English)

1 reference

3 December 2017

1 reference

B Pouzet

1

1 reference

3 December 2017

T Mow

series ordinal

2

1 reference

3 December 2017

M Kreilgaard

series ordinal

3

1 reference

3 December 2017

S Velschow

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Pharmacology, Biochemistry and Behavior

3 December 2017

published in

1 reference

3 December 2017

volume

75

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

133-140

1 reference

Pharmacokinetics and tissue distribution of olanzapine in rats

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Body weight gain induced by antipsychotic drugs: mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Long term administration of some antipsychotic drugs increases body weight and feeding in rats. Are D2 dopamine receptors involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Puberty modifies sulpiride effects on body weight in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Tamoxifen prevents sulpiride-induced weight gain in female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Amantadine in the treatment of neuroleptic-induced obesity in rats: behavioral, endocrine and neurochemical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Mechanism of the neuroleptic-induced obesity in female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: bodyweight, food intake, body composition, hormones and glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Linear pharmacokinetics of haloperidol in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Characterization of olanzapine-induced weight gain in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Identification of a deletion variant in the gene encoding the human alpha(2A)-adrenergic receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Brain histamine and feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Effects of acute versus chronic treatment with typical or atypical antipsychotics on d-amphetamine-induced sensorimotor gating deficits in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Mechanism of the body weight increase induced by systemic sulpiride

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Olanzapine: pharmacology, pharmacokinetics and therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Atypical antipsychotics and weight gain--a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2803%2900042-X

7 January 2021

10.1016/S0091-3057(03)00042-X

Identifiers

DOI

1 reference

3 December 2017

1 reference